Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CJ27 I'll check that out. Thanks.
$MSTX Top Institutional Holders
Holder Shares % Out Value* Reported
Baker Brothers Advisors, LLC 3,000,000 2.63 2,040,000 Mar 31, 2014
Vanguard Group, Inc. (The) 2,610,237 2.29 1,774,961 Mar 31, 2014
Franklin Resources, Inc 11,946,100 10.47 8,123,348 Mar 31, 2014
Morgan Stanley 884,099 0.77 601,187 Mar 31, 2014
Deutsche Bank Aktiengesellschaft 625,600 0.55 425,408 Mar 31, 2014
Geode Capital Management, LLC 560,868 0.49 381,390 Mar 31, 2014
MPM Asset Management, LLC 524,853 0.46 356,900 Mar 31, 2014
GRT Capital Partners, LLC 512,476 0.45 348,483 Mar 31, 2014
Iguana Healthcare Management, LLC 500,000 0.44 340,000 Mar 31, 2014
Dimensional Fund Advisors LP 267,698 0.23 182,034 Mar 31, 2014
That the Baker Bros own this gives me confidence. If you don't like this stock then move on, we don't need you to babysit us.
CJ27... Plus one insider alone owns over 7 million share
Which insider is that?
$GTXI looks good.
http://bit.ly/1k8VsDD
$GTXI looks good.
http://bit.ly/1k8VsDD
The world doesn't stop rotating when $heff speaks!
Link to SA article.
http://bit.ly/1k5b7lQ
I doubt it.
Yeah I know who Richie Havens is, I'm an old timer.
At least your team won. Go Bruins.
Yes I'm doing well. Weather finally warming up here in RI.
Ok. It just sounded a little funny. How you doing ero?
A hidden pipeline? Is it a secret? Go to their company page and it's no longer hidden. ;~)
bit.ly/1iL78G4
In this Phase II study, women receiving oral Trimesta plus injectable Copaxone® demonstrated a statistically significant 47 percent decrease in annualized MS relapse rate in the first 12 months of treatment compared to women receiving placebo plus Copaxone (p=0.0306), and a 32 percent decrease in annualized relapse rate at 24 months (p=0.1527). Patients in both treatment arms demonstrated improved scores on the Expanded Disability Status Scale (EDSS) compared to baseline. Cognitive function test scores, as measured by the Paced Auditory Serial Addition Test (PASAT), in women receiving Trimesta plus Copaxone also improved compared to baseline and were significantly different from placebo plus Copaxone at 12 months.
http://yhoo.it/1o2UNlM
bear raid, taking out stops. IMO
I found it.
Apr. 29, 2014 8:40 AM ET
Pitt Hyde & Mason Hawkins Buy >50% Stake In GTx Ahead Of Phase II Results
|
http://bit.ly/1nZm60f
Do you have a link for this?
Here's a site for tracking FDA events.
http://www.biopharmcatalyst.com/
Wrong symbol. This split is for $SNV. This has nothing to do with Synthetic Biologics.
Synovus shareholders approve reverse stock split
Synovus shareholders approved a reverse stock split plan that will give stockholders one share for every seven they own, the company said.
Synovus’ stock closed at $3.28 a share Thursday. While the reverse stock split won’t go into effect until May 19, at the current price, it would mean that an owner of seven shares would have one share worth $22.96.
Columbus-based Synovus, the second-largest banking company based in Georgia, announced the plan in its February proxy filing.
http://bit.ly/1fe4Swm
That's strange. I used Fidelity to buy $FLML and was charged a .1995% SEC fee because it's a French stock-ADR. I've never run into this before. On 500 shares it was $11.77, that's more than my trading fee. Just wondering. Thanks.
Bob did you have to pay a hefty SEC fee when you bought $FLML? It's a french stock.
lasers were these large orders filled today? I can't find them on a 1 minute chart for today.
money I agree 100%. Couple the downtrend in the $IBB with this short attack and upcoming catalysts and you have a great buying opp.
Hi ero. Yeah I'm still here. Good to see you're still here.
$ONCS I believe with all the big block sells today the shorts are attacking the $h@t out of this one. Good buying opp. JMHO
Shorts attacking this stock. Smart people are buying while it's down.
$ONCS 168 block trades totaling 3,355,979 shares.
Time To Back Up The Truck On Cytomedix?
http://bit.ly/1sgGPQx
This just tells Estimated Primary Completion Date
Estimated Enrollment: 260
Study Start Date: November 2013
Estimated Study Completion Date: May 2014
Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
I found this at ClinicalTrials.gov
http://1.usa.gov/1s4lLwL
Synergy Pharmaceuticals Closes Enrollment for Plecanatide Phase 2b Trial in Patients with IBS-C
Download PDF
NEW YORK-- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced it has closed patient enrollment in its plecanatide phase 2b clinical trial in irritable bowel syndrome with constipation (IBS-C).
The clinical trial is being conducted at approximately 70 sites in the United States and includes four doses of plecanatide (0.3mg, 1.0mg, 3.0mg, 9.0mg) plus a placebo arm, taken once daily over a period of 12 weeks. The primary endpoint is change from baseline in the mean number of complete spontaneous bowel movement (CSBM) over the 12 week treatment period. The first patient was dosed on December 27, 2012 and Synergy anticipates reporting topline data in the beginning of the second quarter of 2014.
http://bit.ly/1i10uvx
It's just a reminder of what they have going for them.
$SGYP SYNERGY IS A STRAIGHTFORWARD OPPORTUNITY: TRIAL RESULTS AT DDW BACK PLECANATIDE
Worth reading.
http://bit.ly/O7j7Wy
$DRTX Congrats to people who held.
Those are the reasons I thought it would be close. It was in the AdCom notes.
$DRTX I said a few days ago this would be a close vote. Post #711.
$EXAS Resumes trading at 4:15
It may be a close vote at AdCom.
Found it, thanks.